This article has been updated with quotes and additional information from NCGC Director Christopher Austin.

By Matt Jones

NEW YORK (GenomeWeb News) – The Tox21 program that brings together the National Institutes of Health and the Environmental Protection Agency to develop new ways to predict the effects of chemicals on humans and the environment has gained a new partner in the US Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.